Mirna-dependent mechanisms can activate CD40 signaling/T-cell interactions in the CLL microenvironment, resulting in novel miR-29 regulated by BCR activity-TRAF4-CD40 signaling axis (84). The gene discussed is CD40; the disease is B-cell chronic lymphocytic leukemia.